Subversion of mRNA degradation pathways by EWSR1: FLI1 represents a therapeutic vulnerability in Ewing sarcoma

Many cancers are defined by gene fusions that frequently encode oncogenic transcription factors (TFs), such as EWSR1::FLI1 in Ewing sarcoma (EwS). Here, we report that independently to its canonical roles in transcription, EWSR1::FLI1 also functions as an mRNA decay factor, reshaping mRNA stability...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Galvan, Bartimée (VerfasserIn) , Ongena, Loïc (VerfasserIn) , Bruyr, Jonathan (VerfasserIn) , Fettweis, Gregory (VerfasserIn) , Lucarelli, Eva (VerfasserIn) , Lavergne, Arnaud (VerfasserIn) , Mariavelle, Emeline (VerfasserIn) , O’Grady, Tina M. (VerfasserIn) , Hassoun, Zahrat El Oula (VerfasserIn) , Claes, Margaux (VerfasserIn) , Dubois, Laurence (VerfasserIn) , Lee, Kevin A. W. (VerfasserIn) , Kruys, Véronique (VerfasserIn) , Gueydan, Cyril (VerfasserIn) , Durand, Jules (VerfasserIn) , Hervouet, Eric (VerfasserIn) , Geyer, Florian H. (VerfasserIn) , Banito, Ana (VerfasserIn) , Imle, Roland (VerfasserIn) , Mao, Lianghao (VerfasserIn) , Jayavelu, Ashok Kumar (VerfasserIn) , Grünewald, Thomas G. P. (VerfasserIn) , Cidre-Aranaz, Florencia (VerfasserIn) , Twizere, Jean-Claude (VerfasserIn) , Dequiedt, Franck (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 July 2025
In: Nature Communications
Year: 2025, Jahrgang: 16, Pages: 1-24
ISSN:2041-1723
DOI:10.1038/s41467-025-61725-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41467-025-61725-x
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41467-025-61725-x
Volltext
Verfasserangaben:Bartimée Galvan, Loïc Ongena, Jonathan Bruyr, Gregory Fettweis, Eva Lucarelli, Arnaud Lavergne, Emeline Mariavelle, Tina M. O’Grady, Zahrat El Oula Hassoun, Margaux Claes, Laurence Dubois, Kevin A.W. Lee, Véronique Kruys, Cyril Gueydan, Jules Durand, Eric Hervouet, Florian H. Geyer, Ana Banito, Roland Imle, Lianghao Mao, Ashok K. Jayavelu, Thomas G.P. Grünewald, Florencia Cidre-Aranaz, Jean-Claude Twizere & Franck Dequiedt

MARC

LEADER 00000naa a2200000 c 4500
001 1942767552
003 DE-627
005 20251128111832.0
007 cr uuu---uuuuu
008 251128s2025 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41467-025-61725-x  |2 doi 
035 |a (DE-627)1942767552 
035 |a (DE-599)KXP1942767552 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Galvan, Bartimée  |e VerfasserIn  |0 (DE-588)138294425X  |0 (DE-627)1942769431  |4 aut 
245 1 0 |a Subversion of mRNA degradation pathways by EWSR1  |b FLI1 represents a therapeutic vulnerability in Ewing sarcoma  |c Bartimée Galvan, Loïc Ongena, Jonathan Bruyr, Gregory Fettweis, Eva Lucarelli, Arnaud Lavergne, Emeline Mariavelle, Tina M. O’Grady, Zahrat El Oula Hassoun, Margaux Claes, Laurence Dubois, Kevin A.W. Lee, Véronique Kruys, Cyril Gueydan, Jules Durand, Eric Hervouet, Florian H. Geyer, Ana Banito, Roland Imle, Lianghao Mao, Ashok K. Jayavelu, Thomas G.P. Grünewald, Florencia Cidre-Aranaz, Jean-Claude Twizere & Franck Dequiedt 
264 1 |c 16 July 2025 
300 |b Illustrationen, Diagramme 
300 |a 24 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.11.2025 
520 |a Many cancers are defined by gene fusions that frequently encode oncogenic transcription factors (TFs), such as EWSR1::FLI1 in Ewing sarcoma (EwS). Here, we report that independently to its canonical roles in transcription, EWSR1::FLI1 also functions as an mRNA decay factor, reshaping mRNA stability in EwS. This function participates in EWSR1::FLI1 tumorigenicity and involves interactions of EWSR1::FLI1 with the CCR4-NOT deadenylation complex via its EWSR1-derived low-complexity domain and with the RNA-binding protein HuR/ELAVL1 via its FLI1-derived region. Strikingly, we find that EWSR1::FLI1-mediated mRNA decay antagonizes the normal mRNA protective function of HuR and renders EwS cells highly sensitive to HuR inhibition. Our findings uncover a post-transcriptional function of EWSR1::FLI1 and suggest that targeting mRNA stability mechanisms may offer therapeutic opportunities for EwS. 
650 4 |a Paediatric cancer 
650 4 |a RNA decay 
650 4 |a Sarcoma 
700 1 |a Ongena, Loïc  |e VerfasserIn  |4 aut 
700 1 |a Bruyr, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Fettweis, Gregory  |e VerfasserIn  |4 aut 
700 1 |a Lucarelli, Eva  |e VerfasserIn  |4 aut 
700 1 |a Lavergne, Arnaud  |e VerfasserIn  |4 aut 
700 1 |a Mariavelle, Emeline  |e VerfasserIn  |4 aut 
700 1 |a O’Grady, Tina M.  |e VerfasserIn  |4 aut 
700 1 |a Hassoun, Zahrat El Oula  |e VerfasserIn  |4 aut 
700 1 |a Claes, Margaux  |e VerfasserIn  |4 aut 
700 1 |a Dubois, Laurence  |e VerfasserIn  |4 aut 
700 1 |a Lee, Kevin A. W.  |e VerfasserIn  |4 aut 
700 1 |a Kruys, Véronique  |e VerfasserIn  |4 aut 
700 1 |a Gueydan, Cyril  |e VerfasserIn  |4 aut 
700 1 |a Durand, Jules  |e VerfasserIn  |4 aut 
700 1 |a Hervouet, Eric  |e VerfasserIn  |4 aut 
700 1 |a Geyer, Florian H.  |e VerfasserIn  |4 aut 
700 1 |a Banito, Ana  |e VerfasserIn  |0 (DE-588)1204036594  |0 (DE-627)1689159316  |4 aut 
700 1 |a Imle, Roland  |d 1989-  |e VerfasserIn  |0 (DE-588)1197936203  |0 (DE-627)1680005235  |4 aut 
700 1 |a Mao, Lianghao  |e VerfasserIn  |4 aut 
700 1 |a Jayavelu, Ashok Kumar  |d 1986-  |e VerfasserIn  |0 (DE-588)108102187X  |0 (DE-627)845528149  |0 (DE-576)45389609X  |4 aut 
700 1 |a Grünewald, Thomas G. P.  |d 1980-  |e VerfasserIn  |0 (DE-588)13673426X  |0 (DE-627)585870365  |0 (DE-576)301246432  |4 aut 
700 1 |a Cidre-Aranaz, Florencia  |e VerfasserIn  |0 (DE-588)1230808973  |0 (DE-627)1753154049  |4 aut 
700 1 |a Twizere, Jean-Claude  |e VerfasserIn  |4 aut 
700 1 |a Dequiedt, Franck  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Nature Communications  |d [London] : Springer Nature, 2010  |g 16(2025), Artikel-ID 6537, Seite 1-24  |h Online-Ressource  |w (DE-627)626457688  |w (DE-600)2553671-0  |w (DE-576)331555905  |x 2041-1723  |7 nnas  |a Subversion of mRNA degradation pathways by EWSR1 FLI1 represents a therapeutic vulnerability in Ewing sarcoma 
773 1 8 |g volume:16  |g year:2025  |g elocationid:6537  |g pages:1-24  |g extent:24  |a Subversion of mRNA degradation pathways by EWSR1 FLI1 represents a therapeutic vulnerability in Ewing sarcoma 
856 4 0 |u https://doi.org/10.1038/s41467-025-61725-x  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.nature.com/articles/s41467-025-61725-x  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251128 
993 |a Article 
994 |a 2025 
998 |g 1230808973  |a Cidre-Aranaz, Florencia  |m 1230808973:Cidre-Aranaz, Florencia  |d 140000  |e 140000PC1230808973  |k 0/140000/  |p 23 
998 |g 13673426X  |a Grünewald, Thomas G. P.  |m 13673426X:Grünewald, Thomas G. P.  |d 910000  |d 912000  |e 910000PG13673426X  |e 912000PG13673426X  |k 0/910000/  |k 1/910000/912000/  |p 22 
998 |g 108102187X  |a Jayavelu, Ashok Kumar  |m 108102187X:Jayavelu, Ashok Kumar  |d 50000  |e 50000PJ108102187X  |k 0/50000/  |p 21 
998 |g 1197936203  |a Imle, Roland  |m 1197936203:Imle, Roland  |d 910000  |d 910500  |e 910000PI1197936203  |e 910500PI1197936203  |k 0/910000/  |k 1/910000/910500/  |p 19 
998 |g 1204036594  |a Banito, Ana  |m 1204036594:Banito, Ana  |d 50000  |e 50000PB1204036594  |k 0/50000/  |p 18 
999 |a KXP-PPN1942767552  |e 4815465967 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Subversion of mRNA degradation pathways by EWSR1 FLI1 represents a therapeutic vulnerability in Ewing sarcomaNature Communications","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"part":{"year":"2025","volume":"16","pages":"1-24","extent":"24","text":"16(2025), Artikel-ID 6537, Seite 1-24"},"note":["Gesehen am 13.06.24"],"pubHistory":["2010-"],"title":[{"title_sort":"Nature Communications","title":"Nature Communications"}],"id":{"zdb":["2553671-0"],"eki":["626457688"],"issn":["2041-1723"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"[London] ; [London]","publisher":"Springer Nature ; Nature Publishing Group UK","dateIssuedDisp":"[2010]-"}],"recId":"626457688"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"16 July 2025"}],"title":[{"title":"Subversion of mRNA degradation pathways by EWSR1","subtitle":"FLI1 represents a therapeutic vulnerability in Ewing sarcoma","title_sort":"Subversion of mRNA degradation pathways by EWSR1"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"24 S."}],"id":{"doi":["10.1038/s41467-025-61725-x"],"eki":["1942767552"]},"recId":"1942767552","person":[{"given":"Bartimée","display":"Galvan, Bartimée","family":"Galvan","role":"aut"},{"role":"aut","family":"Ongena","display":"Ongena, Loïc","given":"Loïc"},{"display":"Bruyr, Jonathan","given":"Jonathan","role":"aut","family":"Bruyr"},{"given":"Gregory","display":"Fettweis, Gregory","role":"aut","family":"Fettweis"},{"role":"aut","family":"Lucarelli","given":"Eva","display":"Lucarelli, Eva"},{"display":"Lavergne, Arnaud","given":"Arnaud","role":"aut","family":"Lavergne"},{"family":"Mariavelle","role":"aut","given":"Emeline","display":"Mariavelle, Emeline"},{"role":"aut","family":"O’Grady","given":"Tina M.","display":"O’Grady, Tina M."},{"family":"Hassoun","role":"aut","given":"Zahrat El Oula","display":"Hassoun, Zahrat El Oula"},{"role":"aut","family":"Claes","display":"Claes, Margaux","given":"Margaux"},{"family":"Dubois","role":"aut","given":"Laurence","display":"Dubois, Laurence"},{"family":"Lee","role":"aut","given":"Kevin A. W.","display":"Lee, Kevin A. W."},{"display":"Kruys, Véronique","given":"Véronique","family":"Kruys","role":"aut"},{"given":"Cyril","display":"Gueydan, Cyril","family":"Gueydan","role":"aut"},{"role":"aut","family":"Durand","display":"Durand, Jules","given":"Jules"},{"family":"Hervouet","role":"aut","display":"Hervouet, Eric","given":"Eric"},{"display":"Geyer, Florian H.","given":"Florian H.","role":"aut","family":"Geyer"},{"given":"Ana","display":"Banito, Ana","role":"aut","family":"Banito"},{"display":"Imle, Roland","given":"Roland","family":"Imle","role":"aut"},{"family":"Mao","role":"aut","display":"Mao, Lianghao","given":"Lianghao"},{"display":"Jayavelu, Ashok Kumar","given":"Ashok Kumar","role":"aut","family":"Jayavelu"},{"display":"Grünewald, Thomas G. P.","given":"Thomas G. P.","role":"aut","family":"Grünewald"},{"role":"aut","family":"Cidre-Aranaz","given":"Florencia","display":"Cidre-Aranaz, Florencia"},{"role":"aut","family":"Twizere","given":"Jean-Claude","display":"Twizere, Jean-Claude"},{"display":"Dequiedt, Franck","given":"Franck","family":"Dequiedt","role":"aut"}],"note":["Gesehen am 28.11.2025"],"name":{"displayForm":["Bartimée Galvan, Loïc Ongena, Jonathan Bruyr, Gregory Fettweis, Eva Lucarelli, Arnaud Lavergne, Emeline Mariavelle, Tina M. O’Grady, Zahrat El Oula Hassoun, Margaux Claes, Laurence Dubois, Kevin A.W. Lee, Véronique Kruys, Cyril Gueydan, Jules Durand, Eric Hervouet, Florian H. Geyer, Ana Banito, Roland Imle, Lianghao Mao, Ashok K. Jayavelu, Thomas G.P. Grünewald, Florencia Cidre-Aranaz, Jean-Claude Twizere & Franck Dequiedt"]},"language":["eng"]} 
SRT |a GALVANBARTSUBVERSION1620